Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Phase 3 Trial
Recent news which mentions Phase 3 Trial
< Previous
1
2
3
4
5
6
7
8
Next >
Galmed's NASH Candidate Shows Clinically Significant Effect On Fibrosis Improvement
November 08, 2021
Tickers
GLMD
Tags
Non Alcoholic steatohepatitis
Benzinga
Phase 3 Trial
From
Benzinga
GlaxoSmithKline Spotlights Encouraging Data For Anemia Drug
November 08, 2021
Tickers
GSK
Tags
General
Benzinga
Chronic Kidney Disease
From
Benzinga
Bristol Myers' Opdivo Combo Meets Endpoint Goal In Lung Cancer Trial
November 08, 2021
Tickers
BMY
Tags
Market News
News
General
From
Benzinga
Regeneron-Roche's COVID-19 Treatment Shows Long Term Benefit After Single Dose
November 08, 2021
Tickers
REGN
RHHBF
RHHBY
RHHVF
Tags
Biotech
REGN
RHHBF
From
Benzinga
Why Did Deciphera Stock Plunged 70% Today?
November 05, 2021
Tickers
DCPH
NVS
PFE
Tags
Benzinga
PFE
Short Ideas
From
Benzinga
Galmed Reveals Early Aramchol Data From Late-Stage NASH Trial
November 01, 2021
Tickers
GLMD
Tags
Non Alcoholic steatohepatitis
Benzinga
Phase 3 Trial
From
Benzinga
Teva Reports Encouraging Data From Late-Stage Schizophrenia Trial
November 01, 2021
Tickers
TEVA
Tags
Movers
Phase 3 Trial
Trading Ideas
From
Benzinga
New Data Reaffirms Merck's Keytruda In Extending Survival In Melanoma Patients
November 01, 2021
Tickers
BMY
MRK
Tags
BMY
MRK
General
From
Benzinga
AbbVie's Major Depressive Disorder Candidate Shows Mixed Result In Late-Stage Trials
October 29, 2021
Tickers
ABBV
Tags
Biotech
Market News
News
From
Benzinga
AstraZeneca's Imfinzi/Chemo Combo Strikes First Immunotherapy Wins In Bile Duct Cancer Trial
October 26, 2021
Tickers
AZN
AZNCF
Tags
Phase 3 Trial
AZNCF
Biotech
From
Benzinga
Why Are Radius Health Shares Soaring Today?
October 20, 2021
Tickers
RDUS
Tags
why it's moving
News
Market News
From
Benzinga
ObsEva Presents Linzagolix Data From Uterine Fibroid Trials
October 20, 2021
Tickers
OBSV
Tags
Benzinga
Uterine Fibroids
Phase 3 Trial
From
Benzinga
ImmunityBio Meets Endpoint In Second Indication Cohort In Bladder Cancer Trial
October 19, 2021
Tickers
IBRX
Tags
Health Care
Briefs
Phase 2 Trial
From
Benzinga
Edesa Biotech Shares Gain As Its COVID-19 Antibody Shows Favorable Mortality Reductions
October 19, 2021
Tickers
EDSA
Tags
Biotech
General
EDSA
From
Benzinga
Why Did Galera Therapeutics Shares Plunge To All Time Lows Today?
October 19, 2021
Tickers
GRTX
Tags
neck cancer
Biotech
News
From
Benzinga
Entasis Shares Rally On Positive Data From Drug-Resistant Bacterial Infection Candidate
October 19, 2021
Tickers
ETTX
Tags
Trading Ideas
Health Care
Briefs
From
Benzinga
Biogen's Antisense Candidate Flunks In Late-Stage Neurodegenerative Disorder Trial
October 18, 2021
Tickers
BIIB
IONS
Tags
Benzinga
IONS
Movers
From
Benzinga
Phathom's Vonoprazan Non-Inferior To Proton Pump Inhibitor For Esophagitis Inflammation
October 18, 2021
Tickers
PHAT
Tags
Phase 3 Trial
Movers
Briefs
From
Benzinga
Why Are Valneva's Shares Trading Higher Monday Premarket?
October 18, 2021
Tickers
AZN
DVAX
VALN
Tags
Benzinga
AZN
Small Cap
From
Benzinga
Sarepta's Duchenne Gene Therapy Shows Sustained Functional Improvements
October 11, 2021
Tickers
RHHBY
SRPT
Tags
Briefs
Trading Ideas
Health Care
From
Benzinga
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
Tickers
AZN
AZNCF
GSK
LLY
Tags
Benzinga
AZN
Health Care
From
Benzinga
AbbVie Touts Additional Rinvoq Data In Inflammatory Spinal Arthritis
October 07, 2021
Tickers
ABBV
Tags
Benzinga
ABBV
Arthritis
From
Benzinga
Brickell Biotech Aces Pivotal Sofpironium Trials In Patients With Excessive Underarm Sweating
October 07, 2021
Tickers
BBI
Tags
Benzinga
Phase 3 Trial
BBI
From
Benzinga
Cassava Sciences Starts Late-Stage Simufilam Study In Alzheimer's Patients
October 06, 2021
Tickers
SAVA
Tags
News
Market News
General
From
Benzinga
Why Did RedHill Biopharma Shares Jump 12% Monday?
October 04, 2021
Tickers
RDHL
Tags
Benzinga
Briefs
Trading Ideas
From
Benzinga
Galapagos Assumes Responsibility Of Late-Stage Filgotinib Trial In Crohn's Disease
October 04, 2021
Tickers
GILD
GLPG
GLPGF
Tags
Briefs
Health Care
Trading Ideas
From
Benzinga
Merck COVID-19 Oral Antiviral Cuts Risk of Hospitalization, Death By 50%
October 01, 2021
Tickers
MRK
Tags
Biotech
General
News
From
Benzinga
AbbVie Unveils New Durable Risankizumab Data In Psoriatic Arthritis
September 30, 2021
Tickers
ABBV
Tags
Arthritis
Briefs
Health Care
From
Benzinga
Minerva Posts Positive Bioequivalence Results For Schizophrenia Candidate Formulations
September 30, 2021
Tickers
NERV
Tags
Briefs
Health Care
Trading Ideas
From
Benzinga
Eli Lilly Shares Positive Tirzepatide Data At EASD Annual Meeting
September 30, 2021
Tickers
LLY
Tags
General
Market News
LLY
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today